Imugene (ASX:IMU) - Managing Director & CEO, Leslie Chong
Managing Director & CEO, Leslie Chong
Source: Imugene
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Imugene (IMU) receives a South Korea patent grant for its HER-Vaxx Immunotherapy
  • The patent will protect the composition and method of the product to 2036
  • Importantly, South Korea is a selected country to conduct the nextHERIZON Phase 2 clinical trial in 2022
  • South Korea has one of the highest incidence rates of gastric cancer around the world, with approximately one in five cases considered HER2 positive
  • On the market this morning, Imugene is down 2.56 per cent and trading at 38 cents per share

Imugene (IMU) has received a South Korea patent grant for its HER-Vaxx immunotherapy.

HER-Vaxx is a b-cell activating immunotherapy designed to treat tumours that over-express the Her-2/neu receptor, such as gastric, breast, ovarian, lung and pancreatic cancers.

The patent will protect the composition and method of the product to 2036.

Importantly, South Korea is a selected country to conduct the nextHERIZON Phase 2 clinical trial in 2022. This study is a combination of HER-Vaxx with chemotherapy or pembrolizumab.

South Korea has one of the highest incidence rates of gastric cancer around the world, with approximately one in five cases considered HER2 positive. Approximately 75 per cent of all gastric cancer diagnoses are in Asia.

Speaking on the patent rant is Managing Director and CEO Leslie Chong.

“Attaining the key South Korean patent, on top of gaining protection in Japan and China in 2021, is a very important milestone,” Ms Chong said.

“This will protect HER-Vaxx in the world’s largest HER-2 positive gastric cancer markets until 2036.”

On the market this morning, Imugene was down 2.56 per cent and is trading at 38 cents per share at 10:21 am AEDT.

IMU by the numbers
More From The Market Online

Week 13 Wrap: Easter bunny delivers new all time high for ASX200

Another week, another all time high. The ASX200 clocked 7,901pts on Thursday for the first time…
The Market Online Video

Market Close: Green lights up on ASX for Easter hunt go

The ASX200 closed the day in record territory - nearly a per cent up with every…

Market shrugs as Fisher & Paykel announces mass recall

Fisher & Paykel has initiated a voluntary limited recall of batches of Airvo 1 and my…
The Market Online Video

Market Update: ASX glows red hot with another hit record

The ASX200 is trading up, hitting a new high of 7901 point and eclipsing the last…